Sol-Gel Technologies Net Income

The latest net income for SLGL is $-16M as of June 2026. That compares with $-3.4M in the prior-year period — down 379.1% year over year. That is below the Healthcare sector average of $17B. Investors often review this figure alongside Sol-Gel Technologies's historical trend and sector peers before judging valuation or financial health.

Over the past year, SLGL's net income moved from $-3.4M to $-16M — a 379.1% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Sol-Gel Technologies's operating scale or balance-sheet position.

Against Healthcare companies, SLGL currently prints $-16M for net income, while the sector average sits near $17B. That is roughly 100.1% below the sector mean. Large gaps often invite a closer look at Sol-Gel Technologies's growth, margins, and balance sheet.

A net income figure of $-16M for SLGL is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $17B. Explore the charts below for those layers of context.

After noting SLGL's net income ($-16M), review year-over-year change from $-3.4M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.